+ All Categories
Home > Documents > Academic Half-Day Treatment of Epilepsy

Academic Half-Day Treatment of Epilepsy

Date post: 24-Feb-2016
Category:
Upload: brina
View: 41 times
Download: 0 times
Share this document with a friend
Description:
Academic Half-Day Treatment of Epilepsy. Ruba Benini & Abdullah Tawakul July 25 th , 2012. Preamble. Epilepsy is the second most common neurological condition after headache Worldwide prevalence of 1% with a cumulative incidence of 2-4%. - PowerPoint PPT Presentation
Popular Tags:
125
Academic Half-Day Treatment of Epilepsy Ruba Benini & Abdullah Tawakul July 25 th , 2012
Transcript
Page 1: Academic Half-Day Treatment of Epilepsy

Academic Half-Day

Treatment of Epilepsy

Ruba Benini & Abdullah TawakulJuly 25th , 2012

Page 2: Academic Half-Day Treatment of Epilepsy

Preamble Epilepsy is the second most common neurological condition after headache

Worldwide prevalence of 1% with a cumulative incidence of 2-4%.

The incidence of epilepsy is highest in the very young and the very old.

Hauser et al., 1996

Page 3: Academic Half-Day Treatment of Epilepsy

Preamble Epilepsy is not a single disease entity but rather an umbrella term used to denote a

variety of disorders with different etiologies but with seizures as a common denominator

Port Wine Stain (Sturge-Weber)

Prosencephaly

Mesial Temporal lobe sclerosis

Page 4: Academic Half-Day Treatment of Epilepsy

Preamble Treatment of epilepsy can be broadly divided into:

Medical treatment (anticonvulsants)

Surgical treatment (Focal resections; Hemispherectomy; Callosotomy)

Special diets (Ketogenic diet, Atkinson diet)

Other (Vagal Nerve stimulation, Deep brain stimulation, Transcranial Magnetic Stimulation)

Page 5: Academic Half-Day Treatment of Epilepsy

OUTLINE Approach to a first unprovoked seizure – to treat or

not to treatAdult versus Child

Medical TreatmentWhat anticonvulsants are available to you Mechanisms of actionSome important pharmacokinetic properties to keep

in mindSome dos and don’ts

Surgical TreatmentBrief overview

OthersA few words

Page 6: Academic Half-Day Treatment of Epilepsy
Page 7: Academic Half-Day Treatment of Epilepsy

OUTLINE Approach to a first unprovoked seizure – to

treat or not to treatAdult versus Child

Medical TreatmentWhat anticonvulsants are available to you Mechanisms of actionSome important pharmacokinetic properties to keep

in mindSome dos and don’ts

Surgical TreatmentBrief overview

OthersA few words

Page 8: Academic Half-Day Treatment of Epilepsy

Scenario

25 year old male, presents to the ER for an episode this morning where he was found on the bathroom floor by his girlfriend after she heard a big bang.

Consult says: r/o seizure.

What is a seizure?What do you want to know?How do you take a seizure

history?

Page 9: Academic Half-Day Treatment of Epilepsy

Scenario

25 year old male, presents to the ER for an episode this morning where he was found on the bathroom floor by his girlfriend after she heard a big bang.

Consult says: r/o seizure.

What is a seizure?What do you want to know?How do you take a seizure

history?

Page 10: Academic Half-Day Treatment of Epilepsy

Definitions

What is a Seizure:

• Clinical event characterized by transient neurological signs and/or symptoms (motor, sensory, level of consciousness)

• That arise due to abnormal and excessive discharges from hyperexcitable, synchronized neuronal networks

Page 11: Academic Half-Day Treatment of Epilepsy

Scenario

25 year old male, presents to the ER for an episode this morning where he was found on the bathroom floor by his girlfriend after she heard a big bang.

Consult says: r/o seizure.

What is a seizure?What do you want to know?How do you take a seizure

history?

Page 12: Academic Half-Day Treatment of Epilepsy

Approach to a first Seizure

HISTORY!

HISTORY!

HISTORY!

• Is this really an epileptic seizure or a seizure mimic?

• What type of seizure was it? (Seizure Semiology)

• Can you identify a particular epilepsy syndrome?

• What is the etiology of the seizure?

Page 13: Academic Half-Day Treatment of Epilepsy

Approach to a first Seizure

• Is this really an epileptic seizure or a seizure mimic?

Suggested Reading: Crompton and Berkovic (2009) The borderland of epilepsy: clinical and molecular features of phenomena that mimic epileptic seizures. Lancet Neurology

Page 14: Academic Half-Day Treatment of Epilepsy

Approach to a first Seizure• What type of seizure was it?

Generalized seizures Focal (Partial) Seizures

•Tonic-clonic (Grand mal)•Absence (Petit mal) •Myoclonic •Tonic •Clonic •Atonic

•Simple partial•Complex partial•Complex partial with secondary generalization

Complex partial seizures Impairment of consciousness Usually originate in frontal or

temporal lobe Maybe preceded by auras May involve automatisms

Simple partial seizures No loss of consciousness May manifest as motor signs,

autonomic symptoms, somatosensory, special sensory symptoms or psychic symptoms

Page 15: Academic Half-Day Treatment of Epilepsy

Approach to a first Seizure• What type of seizure was it?

Suggested Reading: Berg et al. (2010) Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia.

Page 16: Academic Half-Day Treatment of Epilepsy

Approach to a first Seizure• Can you identify a particular

epilepsy syndrome?

Suggested Reading: Berg et al. (2010) Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia.

Page 17: Academic Half-Day Treatment of Epilepsy

Definitions

What is an Epilepsy Syndrome:

Clinical entity with relatively consistent clinical features that is defined by seizure semiology, etiology, EEG signature, neurologic status, prognosis and in some cases response to specific anticonvulsants

Page 18: Academic Half-Day Treatment of Epilepsy

Approach to a first Seizure• Can you identify a

particular epilepsy syndrome?

Suggested Reading: Berg et al. (2010) Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia.

Page 19: Academic Half-Day Treatment of Epilepsy

Approach to a first Seizure• What is the

etiology?

Page 20: Academic Half-Day Treatment of Epilepsy

Back to Scenario

25 year old male, presents to the ER for an episode this morning where he was found on the bathroom floor by his girlfriend after she heard a big bang.

Consult says: r/o seizure.

First unprovoked SeizureGeneralized seizure

Patient asks if he has epilepsy?Do you treat?

Page 21: Academic Half-Day Treatment of Epilepsy

Definitions

What is Epilepsy:

Chronic condition characterized by recurrent, usually spontaneous, epileptic seizures

Two or more unprovoked seizures

Page 22: Academic Half-Day Treatment of Epilepsy

Back to Scenario

25 year old male, presents to the ER for an episode this morning where he was found on the bathroom floor by his girlfriend after she heard a big bang.

Consult says: r/o seizure.

First unprovoked SeizureGeneralized seizure

Patient asks if he has epilepsy?Do you treat?

Page 23: Academic Half-Day Treatment of Epilepsy

Approach to first unprovoked seizure

• Risk of recurrence after first seizure: 30 to 55% over 2 to 5 years

• Treatment of first seizure reduces risk of recurrence by 50% but does not alter the risk of developing epilepsy

• There is no evidence that delaying treatment alters prognosis (chances for eventual seizure control are not reduced by delaying AED therapy)

Page 24: Academic Half-Day Treatment of Epilepsy

Approach to first unprovoked seizure

First unprovoked epileptic seizure

No treatment

Exceptions: Early treatment is justifiable for patients in whom recurrence of seizure would have significant consequences related to driving, working and general safety

Page 25: Academic Half-Day Treatment of Epilepsy

Hirtz et al., 2003

Summary of Guideline1. Treatment with AED is not indicated for the prevention of the development of

epilepsy (Level B).2. Treatment with AED may be considered in circumstances where the benefits of

reducing the risk of a second seizure outweigh the risks of pharmacologic and psychosocial side effects (Level B).

Page 26: Academic Half-Day Treatment of Epilepsy

OUTLINE Approach to a first unprovoked seizure – to treat or

not to treatAdult versus Child

Medical TreatmentWhat anticonvulsants are available to you Mechanisms of actionSome important pharmacokinetic properties to keep

in mindSome dos and don’ts

Surgical TreatmentBrief overview

OthersA few words

Page 27: Academic Half-Day Treatment of Epilepsy

In epilepsy, there is a pathologic imbalance between inhibitory and excitatory processes

Inhibition

Excitation

Treatment of Epilepsy(Anticonvulsants)

Anticonvulsants control seizures either by increasing inhibition or decreasing excitation

InhibitionExcitation

• Voltage-gated Na channels

• Voltage-gated Ca channels

• Glutamatergic excitation

• GABAergic transmission

Page 28: Academic Half-Day Treatment of Epilepsy

Treatment of Epilepsy(Anticonvulsants)

Page 29: Academic Half-Day Treatment of Epilepsy

Mechanism of action

Important side-effects

Pharmacokinetics

How do you choose the first drug

Special considerations (pregnancy, etc)

Treatment of Epilepsy(Anticonvulsants)

Page 30: Academic Half-Day Treatment of Epilepsy

Match the following anticonvulsants

to their mechanism(s) of action

Page 31: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Phenytoin (Dilantin)

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Page 32: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Phenobarbital

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Page 33: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Carbamazepine(Tegretol)

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

OxCarbamazepine(Trileptal)

Page 34: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Clobazam(Frisium)

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

DiazepamLorazepamMidazolamClonazepam

Page 35: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Lamotrigine(Lamictal)

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Page 36: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Levetiracetam(Keppra)

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Page 37: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Lacosamide(Vimpat)

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Binds to CRMP-2

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Page 38: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Valproic Acid(Epival, Depakene)

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Page 39: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Valproic Acid(Epival, Depakene)

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Page 40: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Ethosuximide(Zarontin)

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Page 41: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Topiramate (Topamax)

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA (non-NMDA) receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Page 42: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Vigabatrin(Sabril)

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Page 43: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Tiagabine

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Page 44: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Gabapentin(Neurontin)

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Pregabalin(Lyrica)

Page 45: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Felbamate

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Page 46: Academic Half-Day Treatment of Epilepsy

Anticonvulsants(Mechanism of Action)

Rufinimide

Blocks voltage-gated Na channels

Blocks presynaptic release of neurotransmitter by blocking SV 2A

GABA(A) receptor agonist

Blocks voltage-gated Ca channels

Stabilizes slowly-inactivated voltage-gated Na channels

Blocks NMDA receptors

Blocks AMPA receptors

Blocks GAT-1 and prevents uptake of GABA from synapse

Blocks metabolism of GABA by inhibiting GABA-T

Blocks T-type Calcium channels

Increases intracellular GABA levels

Blocks presynaptic release of neurotransmitter by N-type Ca channels

Page 47: Academic Half-Day Treatment of Epilepsy

Summary

Panayiotopoulos (2010)

Page 48: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: SummaryDrug Mechanism of Action

Phenobarbital Agonist of GABA (A) receptorsAntagonist of N- and L-type voltage-gated Ca channels

Phenytoin Stabilizes inactive state of voltage-gated Na ChannelsInhibit presynaptic release of NT via L-type Ca channels

CarbamazepineOxcarbazepine

Stabilizes inactive state of voltage-gated Na ChannelsInhibit presynaptic release of NT via L-type Ca channels

Valproate Stabilizes inactive state of voltage-gated Na ChannelsIncreases GABA levelsBlocks NMDA glutamate receptorsBlocks T-type voltage gated Ca channels

Ethosuximide Antagonist of T-type voltage-gated Calcium channels

Benzodiazepines (clobazam)

Agonist of GABA (A) receptors

Page 49: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: SummaryDrug Mechanism of Action

Lamotrigine Stabilizes inactive state of voltage-gated Na ChannelsIncreases intracellular GABA levelsMay act at N, P/Q type voltage-gated Calcium channels

Vigabatrin Blocks metabolism of GABA through GABA-T

GabapentinPregabalin

Blocks presynaptic release of neurotransmitters via N-type Calcium channelsIncreases intracellular GABA levels

Tiagabine Blocks GAT-1 and prevents uptake of GABA from synapse

Felbamate Blocks NMDA glutamate receptorsEnhances GABA(A) receptor transmissionUnclear effect on voltage-gated Na channels

Levetiracetam

Blocks presynaptic vesicle recycling through SV 2A

Page 50: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: SummaryDrug Mechanism of Action

Lacosamide Stabilizes slowly-inactivated Na channelsBinds to CRMP-2

Topiramate Blocks AMPA/Kainate glutamate receptorsBlocks L-type voltage gated Ca channelsUnclear effect on voltage-gated Na channelsMay enhance GABA(A) receptor transmissionWeak inhibitor of carbonic anhydrase

Page 51: Academic Half-Day Treatment of Epilepsy

Anticonvulsants and side-effects

Page 52: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effects

Which of the following AED can cause somnolence?

PhenobarbitalValproic acidTopiramateVigabatrinPhenytoinLamictalPrimidoneClobazam

PART I: What makes nerve cells excitable?

Page 53: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effects

Which of the following AED can cause somnolence?

PhenobarbitalValproic acidTopiramateVigabatrinPhenytoinLamictalPrimidoneClobazam

PART I: What makes nerve cells excitable?

Page 54: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effects

Which of the following are side-effects of Topiramate?

1. Blurry vision2. Metabolic acidosis3. Paresthesias4. Ataxia5. Renal stones6. Mental slowing with speech and memory disturbance7. Psychosis8. Alopecia9. Weight gain10.Glaucoma

PART I: What makes nerve cells excitable?

Page 55: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effects

Which of the following are side-effects of Topiramate?

1. Blurry vision2. Metabolic acidosis3. Paresthesias4. Ataxia5. Renal stones6. Mental slowing with speech and memory

disturbance7. Psychosis8. Alopecia9. Weight gain10.Glaucoma

PART I: What makes nerve cells excitable?

Page 56: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effectsWhich of the following are side-effects of

Phenytoin?

1. Blurry vision2. Metabolic acidosis3. Paresthesias4. Ataxia5. Renal stones6. Hirsutism7. Psychosis8. Osteoporosis9. Alopecia10.Weight gain11.Gum hyperplasia12.Stevens-Johnson syndrome13.Blood dyscrasias

PART I: What makes nerve cells excitable?

Page 57: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effectsWhich of the following are side-effects of

Phenytoin?

1. Blurry vision2. Metabolic acidosis3. Paresthesias4. Ataxia5. Renal stones6. Hirsutism7. Psychosis8. Osteoporosis9. Alopecia10.Weight gain11.Gum hyperplasia12.Stevens-Johnson syndrome13.Blood dyscrasias

PART I: What makes nerve cells excitable?

Page 58: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effectsWhich of the following are side-effects of Valproic

acid?

1. Blurry vision2. Dysfunctional platelets3. Paresthesias4. Ataxia5. Birth defects6. Hirsutism7. Psychosis8. Abdominal pain and other GI symptoms9. Alopecia10.Weight gain11.Liver failure12.Stevens-Johnson syndrome13.Blood dyscrasias

PART I: What makes nerve cells excitable?

Page 59: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effectsWhich of the following are side-effects of Valproic

acid?

1. Blurry vision2. Dysfunctional platelets3. Paresthesias4. Ataxia5. Birth defects6. Hirsutism7. Psychosis8. Abdominal pain and other GI symptoms9. Alopecia10.Weight gain11.Liver failure12.Stevens-Johnson syndrome13.Hyperammonemia

PART I: What makes nerve cells excitable?

Page 60: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effectsWhich of the following are side-effects of

Carbamazepine?

1. Ataxia2. SJS3. Visual field loss4. SIADH5. Diplopia6. Hepatotoxicity7. Aplastic anemia8. Paresthesias

PART I: What makes nerve cells excitable?

Page 61: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effectsWhich of the following are side-effects of

Carbamazepine?

1. Ataxia2. SJS3. Visual field loss4. SIADH5. Diplopia6. Hepatotoxicity7. Aplastic anemia8. Paresthesias

PART I: What makes nerve cells excitable?

Page 62: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effectsWhich of the following anticonvulsants cause

peripheral visual field defects?

1. Tegretol2. Phenobarbital3. Vigabatrin4. Clobazam5. Valproic acid6. Dilantin

PART I: What makes nerve cells excitable?

Page 63: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effectsWhich of the following anticonvulsants cause

peripheral visual field defects?

1. Tegretol2. Phenobarbital3. Vigabatrin4. Clobazam5. Valproic acid6. Dilantin

PART I: What makes nerve cells excitable?

Bonus Point: What type of seizures is Vigabatrin used for?

Page 64: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effectsWhich of the following anticonvulsant(s) can be used

in patients with concomitant psychiatric disorders for mood stabilization?

1. Levetiracetam2. Phenobarbital3. Oxcarbazepine4. Vigabatrin5. Clobazam6. Valproic acid7. Dilantin8. Lamotrigine

PART I: What makes nerve cells excitable?

Page 65: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effectsWhich of the following anticonvulsant(s) can be used

in patients with concomitant psychiatric disorders for mood stabilization?

1. Levetiracetam2. Phenobarbital3. Oxcarbazepine4. Vigabatrin5. Clobazam6. Valproic acid7. Dilantin8. Lamotrigine

PART I: What makes nerve cells excitable?

Page 66: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effectsWhich of the following anticonvulsant(s) can cause

SJS

1. Levetiracetam2. Phenobarbital3. Oxcarbazepine4. Vigabatrin5. Clobazam6. Carbamazepine7. Phenytoin8. Ethosuximide 9. Valproic acid10.Felbamate11.Lamotrigine12.Lacosamide

PART I: What makes nerve cells excitable?

Page 67: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Side-effectsWhich of the following anticonvulsant(s) can cause

SJS

1. Levetiracetam2. Phenobarbital3. Oxcarbazepine4. Vigabatrin5. Clobazam6. Carbamazepine7. Phenytoin8. Ethosuximide 9. Valproic acid10.Felbamate11.Lamotrigine12.Lacosamide

PART I: What makes nerve cells excitable?

Page 68: Academic Half-Day Treatment of Epilepsy

Continuum (2010)

Anticonvulsants: Side-effects

Page 69: Academic Half-Day Treatment of Epilepsy

Which of the following anticonvulsants

need to be monitored and why?1. Phenytoin2. Phenobarbital3. Clobazam4. Topamax5. Carbamazepine6. Oxcarbamazepine7. Levetiracetam8. Valproic acid9. Gabapentin10.Pregabalin11.Ethosuximide12.Lacosamide13.Vigabatrin

Page 70: Academic Half-Day Treatment of Epilepsy

Anticonvulsants and Pharmacokinetics

Page 71: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: PharmacokineticsAll of the following anticonvulsants are hepatically

excreted except:

1. Phenobarbital2. Oxcarbazepine3. Carbamazepine4. Phenytoin5. Levetiracetam 6. Valproic acid7. Lamotrigine8. Lacosamide

PART I: What makes nerve cells excitable?

Page 72: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: PharmacokineticsAll of the following anticonvulsants are hepatically

excreted except:

1. Phenobarbital2. Oxcarbazepine3. Carbamazepine4. Phenytoin5. Levetiracetam 6. Valproic acid7. Lamotrigine8. Lacosamide

PART I: What makes nerve cells excitable?

Page 73: Academic Half-Day Treatment of Epilepsy

Panayiotopoulos (2010)

Anticonvulsants: Pharmacokinetics

Page 74: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Pharmacokinetics

Which of the following antoconvulsants decrease efficacy of OCP?

1. Carbamazepine/Oxcarbazepine2. Phenobarbital3. Valproic acid4. Topiramate5. Vigabatrin6. Phenytoin7. Lamictal8. Primidone

PART I: What makes nerve cells excitable?

Page 75: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Pharmacokinetics

Which of the following antoconvulsants decrease efficacy of OCP?

1. Carbamazepine/Oxcarbazepine2. Phenobarbital3. Valproic acid4. Topiramate5. Vigabatrin6. Phenytoin7. Lamictal (level decreases with OCP use)8. Primidone

PART I: What makes nerve cells excitable?

http://basic-clinical-pharmacology.net/chapter%2024_%20antiseizure%20drugs.htm

Page 76: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: PharmacokineticsPART I: What makes nerve cells excitable?

Enzyme-Inducers:• Increase rate of

metabolism of drugs metabolized by CYP enzymes

• Results in changes in sex hormone levels and increases clearance of estrogen and progesterone in OCP

• Increase metabolism of Vit D (which is metabolized by liver) → rickets and hypocalcemia in children

Panayiotopoulos (2010)

Page 77: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: PharmacokineticsWhich of the following anticonvulsants will be

increased with the concomitant use of erythromycin or clarithromycin?

1. Carbamazepine2. Phenobarbital3. Valproic acid4. Topiramate5. Vigabatrin6. Phenytoin7. Lamictal8. Primidone

PART I: What makes nerve cells excitable?

Page 78: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: PharmacokineticsWhich of the following anticonvulsants will be

increased with the concomitant use of erythromycin or clarithromycin?

1. Carbamazepine2. Phenobarbital3. Valproic acid4. Topiramate5. Vigabatrin6. Phenytoin7. Lamictal8. Primidone

PART I: What makes nerve cells excitable?

Page 79: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: PharmacokineticsA patient who drinks lots of grapefruit juice

presents with toxic levels of which of the following anticonvulsants:

1. Carbamazepine2. Phenobarbital3. Valproic acid4. Topiramate5. Vigabatrin6. Phenytoin7. Lamictal8. Primidone

PART I: What makes nerve cells excitable?

Page 80: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: PharmacokineticsA patient who drinks lots of grapefruit juice

presents with toxic levels of which of the following anticonvulsants:

1. Carbamazepine (grapefruit inhibits CYP3A4)2. Phenobarbital3. Valproic acid4. Topiramate5. Vigabatrin6. Phenytoin7. Lamictal8. Primidone

PART I: What makes nerve cells excitable?

Page 81: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: PharmacokineticsAnticonvulsants (phenytoin, phenobarbital) can

generally have the following effect on warfarin:

1. Increase warfarin level2. Decrease warfarin level

PART I: What makes nerve cells excitable?

Page 82: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: PharmacokineticsAnticonvulsants (phenytoin, phenobarbital) can

generally have the following effect on warfarin:

1. Increase warfarin level2. Decrease warfarin level

PART I: What makes nerve cells excitable?

Page 83: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: PharmacokineticsThe pharmacokinetics of phenytoin can be

described as:

1. Non-linear2. Linear3. First-order4. Zero-order

PART I: What makes nerve cells excitable?

Page 84: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: PharmacokineticsThe pharmacokinetics of phenytoin can be

described as:

1. Non-linear2. Linear3. First-order4. Zero-order

PART I: What makes nerve cells excitable?

Page 85: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: PharmacokineticsAn ICU patient with multiple medical problems is

on IV dilantin for the treatment of status epilepticus. What lab variable do you need to order to ascertain the correct dilantin level?

1. Liver enzymes2. Albumin3. CBC4. Urea5. Ammonia

PART I: What makes nerve cells excitable?

Page 86: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: PharmacokineticsAn ICU patient with multiple medical problems is

on IV dilantin for the treatment of status epilepticus. What lab variable do you need to order to ascertain the correct dilantin level?

1. Liver enzymes2. Albumin3. CBC4. Urea5. Ammonia

PART I: What makes nerve cells excitable?

Page 87: Academic Half-Day Treatment of Epilepsy

Special considerations

Page 88: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Special ConsiderationsYou just diagnosed a 16 year old girl with JME.

Which of the following drugs would you not prescibe?

1. Lamictal2. Levetiracetam3. Valproic acid

PART I: What makes nerve cells excitable?

Page 89: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Special ConsiderationsYou just diagnosed a 16 year old girl with JME.

Which of the following drugs would you not prescibe?

1. Lamictal2. Levetiracetam3. Valproic acid

PART I: What makes nerve cells excitable?

Page 90: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Special ConsiderationsPART I: What makes nerve cells excitable?

Page 91: Academic Half-Day Treatment of Epilepsy

Choosing among anticonvulsants

Page 92: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Choosing AEDsWhich of the following are important to consider

when choosing an anticonvulsant

1. Age2. Type of seizure (partial versus generalized)3. Patient characteristics4. Co-morbid conditions5. Cost6. Side-effect profile

Page 93: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Choosing AEDsWhich of the following are important to consider

when choosing an anticonvulsant

1. Age2. Type of seizure (partial versus generalized)3. Patient characteristics4. Co-morbid conditions5. Cost6. Side-effect profile

Page 94: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Choosing AEDsHigh-level evidence for the efficacy for initial

monotherapy of partial seizures exists for which of the following drugs:

1. Phenytoin2. Lamotrigine3. Phenobarbital4. Carbamazepine5. Oxcarbazepine6. Topiramate7. Valproic acid

Page 95: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Choosing AEDsHigh-level evidence for the efficacy for initial

monotherapy of partial seizures exists for which of the following drugs:

1. Phenytoin2. Lamotrigine3. Phenobarbital4. Carbamazepine5. Oxcarbazepine6. Topiramate7. Valproic acid

Page 96: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Choosing AEDsHigh-level evidence for the efficacy for initial

monotherapy of generalized seizures exists for which of the following drugs:

1. Phenytoin2. Lamotrigine3. Phenobarbital4. Carbamazepine5. Oxcarbazepine6. Topiramate7. Valproic acid

Page 97: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Choosing AEDsHigh-level evidence for the efficacy for initial

monotherapy of generalized seizures exists for which of the following drugs:

1. Phenytoin2. Lamotrigine3. Phenobarbital4. Carbamazepine5. Oxcarbazepine6. Topiramate7. Valproic acid

Page 98: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Choosing AEDs8 year old girl with childhood absence epilepsy,

your choice(s) include:

1. Phenytoin2. Ethosuximide3. Phenobarbital4. Lamictal5. Oxcarbazepine6. Topiramate7. Valproic acid

Page 99: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Choosing AEDs8 year old girl with childhood absence epilepsy,

your choice(s) include:

1. Phenytoin2. Ethosuximide3. Phenobarbital4. Lamictal5. Oxcarbazepine6. Topiramate7. Valproic acid

Page 100: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Choosing AEDs16 year old boy with JME, your choice(s) include

all of the following except:

1. Lamictal2. Carbamazepine3. Valproic acid4. Levetiracetam

Page 101: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Choosing AEDs16 year old boy with JME, your choice(s) include

all of the following except:

1. Lamictal2. Carbamazepine3. Valproic acid4. Levetiracetam

Page 102: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: SummaryPART I: What makes nerve cells excitable?

Panayiotopoulos (2010)

Page 103: Academic Half-Day Treatment of Epilepsy

OUTLINE Approach to a first unprovoked seizure – to treat or

not to treatAdult versus Child

Medical TreatmentWhat anticonvulsants are available to you Mechanisms of actionSome important pharmacokinetic properties to keep

in mindSome dos and don’ts

Surgical TreatmentBrief overview

OthersA few words

Page 104: Academic Half-Day Treatment of Epilepsy

Introduction

Approximately 20% to 30% of all patients with epilepsy will have physically, socially, and medically refractory seizure disorders.

Patients with intractable epilepsy are at increased risk for serious morbidity and mortality.

Page 105: Academic Half-Day Treatment of Epilepsy

IntroductionThe goals of therapy in patients with medically

refractory seizures include:

significantly reducing seizure tendency. avoiding adverse effects. permitting the individual to become a

participating and productive member of society.

Page 106: Academic Half-Day Treatment of Epilepsy

WHEN TO DECIDE DRUG THERAPY HAS FAILED

DRE is now defined as ‘failure of adequate trials of two tolerated, appropriately chosen and used AED schedules (whether as monotherapy or in combination) to achieve sustained seizure freedom.

less than 5% to 10%, who have not responded to monotherapy with two appropriate antiepileptic drugs (AEDs) or a combination of two drugs will respond to a third drug.

after treatment with multiple AEDS, 11% and 16% became seizure free. It is interesting that 52% of patients treated surgically in one of these studies became seizure free.

Page 107: Academic Half-Day Treatment of Epilepsy

Who should be referred for surgery

Page 108: Academic Half-Day Treatment of Epilepsy

Surgery outcome

Page 109: Academic Half-Day Treatment of Epilepsy

Pre-surgical evaluation

Page 110: Academic Half-Day Treatment of Epilepsy

Conclusion Epilepsy surgery is highly effective and has

durable benefits, and improves quality of life.

Despite class I evidence and Clinical Practice Guidelines, epilepsy surgery remains underutilized.

The spectrum of patients who may benefit from epilepsy surgery has expanded considerably including younger and older patients and those without apparent MRI lesions.

Page 111: Academic Half-Day Treatment of Epilepsy

Electronic Devices

VNS.Direct Cortical Stimulation.Responsive Neurostimulation System.Stimulation of the Anterior Nucleus of the

Thalamus for Epilepsy Trial.

Page 112: Academic Half-Day Treatment of Epilepsy

VNSVagus nerve stimulation(VNS) is an approved

treatment for intractable partial epilepsy.A VNS is a palliative procedure that may reduce

seizure tendency.In clinical trials, seizure frequency was reduced

by 25% to 30%, an outcome similar to new AED trials.

Day surgery procedure.The left vagus nerve is stimulated rather than

the right because the right plays a role in cardiac function, and stimulating it could have negative cardiac effects.

Page 113: Academic Half-Day Treatment of Epilepsy

Mechanism : Unknown , affect blood flow to different parts of the brain and to affect neurotransmitters, including serotonin and norepinephrine, which are implicated in depression.

common side effects include hoarseness, throat pain, cough, dyspnea and paresthesia.

Page 114: Academic Half-Day Treatment of Epilepsy

THE KETOGENIC DIET

The ketogenic diet was developed before all of the anticonvulsants in current use except phenobarbital.

It fell out of favor with the introduction of phenytoin.

Since 1990 ,the ketogenic diet has resurfaced as it is often very effective in patients who have failed numerous drug trials.

patients on the diet often require lower doses of anticonvulsants and become more alert and less dizzy.

Page 115: Academic Half-Day Treatment of Epilepsy

Description and Mechanism

The classic diet consists of 4 grams of fat for each gram of protein and carbohydrate consumed.

Mechanism : Unknown ,overall changes in brain protein phosphorylation state and particular examples of altered gene expression have been documented.

Early proposals suggesting that cerebral acidosis or changes in electrolyte concentrations are responsible for the diet’s anti seizure effects

Page 116: Academic Half-Day Treatment of Epilepsy

Efficacy The ketogenic diet is a first-line therapy for

patients with seizures associated with certain metabolic disorders.

A number of studies have shown the ketogenic diet to be an effective treatment for medically intractable epilepsy in children.

One of the prospective studies included 51 children from 1 to 8 years of age. At the 12-month follow-up, 10% of the children were seizure free, 22% had a greater than 90% reduction in seizure frequency, and 40% had a greater than 50% reduction.

Page 117: Academic Half-Day Treatment of Epilepsy

With adolescents , 45 patients aged 12 to 19 years, 20 patients remained on the diet at 1 year. Seven had a 50% to 90% reduction in seizure frequency, while six had a greater than 90% reduction.

One recent adult study. This study included 11 adults between age of 32 -45.

At 8 months follow-up, three patients had a 90% decrease in seizure frequency, three patients had a 50% to 89% decrease ,and one patient had a less than 50%decrease. 6 patients discontinued the diet. 2 had no change in their seizure frequency .

Page 118: Academic Half-Day Treatment of Epilepsy

Side Effects and Precaution Common adverse effects in adolescent and adult

trials Included constipation, hypercholesterolemia, Menstrual irregularities, and weight loss.

Kidney stones occur in 6% to7% of children on the diet.

Because valproate is an inhibitor of fatty acid oxidation and decreases hepatic ketogenesis, Valproate is not recommended.

Page 119: Academic Half-Day Treatment of Epilepsy

References:

Deckers et al. Conference Report. Current limitations of antiepileptic drug therapy:a conference review. Epilepsy Research 53 (2003) 1–17.

Joana Guimara˜es, and Jose´ Augusto Mendes Ribeiro. Pharmacology of Antiepileptic Drugs in Clinical Practice. The Neurologist 2010;16:353–357.

Johannessen SI, Landmark CJ. Antiepileptic drug interactions - principles and clinical implications. Curr Neuropharmacol. 2010 Sep;8(3):254-67.

Panayiotopoulos CP. A Clinical Guide to Epileptic Syndromes and Their treatment. Second Edition. 2010.

Continuum. Epilepsy. 2010.

http://basic-clinical-pharmacology.net/chapter%2024_%20antiseizure%20drugs.htm

PART I: What makes nerve cells excitable?

Page 120: Academic Half-Day Treatment of Epilepsy

Questions??

PART I: What makes nerve cells excitable?

Page 121: Academic Half-Day Treatment of Epilepsy

Seizing hold of seizuresGregory L Holmes & Yezekiel Ben-Ari

 

Figure 1. Focal seizures result from a limited group of neurons that fire abnormally because of intrinsic or extrinsic factors.(a) In this simplified diagram, II and III represent epileptic neurons. Because of extensive cell-to-cell connections, termed 'recurrent collaterals', aberrant activity in cells II and III can fire synchronously, resulting in a prolonged depolarization of the neurons. (b) This intense depolarization of epileptic neurons is termed the paroxysmal depolarization shift. The prolonged depolarization results in action potentials and propagation of electrical discharges to other cells. The paroxysmal depolarization shift is largely dependent on glutamate excitation and activation of voltage-gated calcium and sodium channels. After the depolarization, the cell is hyperpolarized by activation of GABA receptors as well as voltage-gated potassium channels. Axons from the abnormal neurons also activate GABAergic inhibitory neurons (green) which reduce the activity in cells II and III in addition to blocking the firing of cells outside the seizure focus (cells I and IV). An electroencephalogram (EEG) recorded during this time would show a spike and a subsequent slow wave. When the balance of excitation and inhibition is further disturbed, there will be a breakdown in containment of the epileptic focus and a seizure will occur. (c) A sustained depolarization without repolarization occurs in many cells during the seizure. An EEG would show repetitive spikes during the seizure. By inducing cells to release galanin, an endogenous anticonvulsant that reduces glutamate release, Haberman et al. successfully increased inhibition and thereby reduced seizure susceptibility.

Page 122: Academic Half-Day Treatment of Epilepsy

Anticonvulsants: Voltage-gated Na channels

• Blockade/modulation of Voltage-gated Na channels is the most common mechanism of action of most of the AEDs

• Bind and stabilize inactive forms of channel → prevent repetitive neuronal firing

CBZ

PHT

VPA

LTG

Oxcarbazepine

Eslicarbazepine

Lacosamide

?Felbamate

Topiramate

Zonisamide

Rufinamide

Page 123: Academic Half-Day Treatment of Epilepsy

Approach to Epilepsy(When to stop treatment)

• Seizure control is possible for most patients with epilepsy

• In a recent study by Brodie et al. (2012, Neurology)• 69% seizure-freedom over 2 years• 61% seizure-freedom over 5 years• 52% seizure-freedom over 10 years

• After many years of seizure-freedom, patient begin to question whether therapy is still necessary

• Desire to discontinue medications:• Side-effects• Cost• Inconvenience• Fear of long-term side-effects

• Risk of recurrence after anticonvulsant discontinuation: 12% to 63% over 2 to 5 years follow-up (majority: 41% or less relapse rate)

Page 124: Academic Half-Day Treatment of Epilepsy

Approach to Epilepsy(When to stop treatment)

Page 125: Academic Half-Day Treatment of Epilepsy

Approach to Epilepsy(When to stop treatment)


Recommended